BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8837328)

  • 21. [Spindle cell carcinoma of breast with neuroendocrine differentiation].
    Ding HY; Gao LX
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medullary and mixed medullary-papillary carcinoma of the thyroid gland.
    Macák J; Vaverková H; Dushová M; Perglerová I
    Pathologica; 1997 Jun; 89(3):317-22. PubMed ID: 9270266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases.
    Matias-Guiu X; LaGuette J; Puras-Gil AM; Rosai J
    Am J Surg Pathol; 1997 Jul; 21(7):754-62. PubMed ID: 9236831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological and functional correlation of thyroid carcinoma by immunohistochemistry.
    Prathiba D; Rao KR; Madhavan M
    Indian J Pathol Microbiol; 1990 Jan; 33(1):35-40. PubMed ID: 2394474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small cell neuroendocrine carcinoma of the urinary bladder. An immunohistochemical and ultrastructural evaluation of 3 cases with a review of the literature.
    Blomjous CE; Thunnissen FB; Vos W; de Voogt HJ; Meijer CJ
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(6):505-12. PubMed ID: 2849230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunocytochemical characterization of neuroendocrine tumours of the larynx.
    Salim SA; Milroy C; Rode J; Corrin B; Hamid Q
    Histopathology; 1993 Jul; 23(1):69-73. PubMed ID: 7690008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine differentiation in non-small cell lung carcinomas.
    Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F
    In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid paraganglioma: a clinicopathologic and immunohistochemical study of three cases.
    LaGuette J; Matias-Guiu X; Rosai J
    Am J Surg Pathol; 1997 Jul; 21(7):748-53. PubMed ID: 9236830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
    Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
    Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
    Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
    Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papillary and mucoepidermoid carcinoma of the thyroid with anaplastic transformation: a case report with histologic and immunohistochemical findings that support a provocative histogenetic hypothesis.
    Cameselle-Teijeiro J; Febles-Pérez C; Sobrinho-Simões M
    Pathol Res Pract; 1995 Dec; 191(12):1214-21. PubMed ID: 8927569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroendocrine differentiation is a common feature of thymic carcinoma.
    Lauriola L; Erlandson RA; Rosai J
    Am J Surg Pathol; 1998 Sep; 22(9):1059-66. PubMed ID: 9737237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial markers in thyroid carcinoma: an immunoperoxidase study.
    Wilson NW; Pambakian H; Richardson TC; Stokoe MR; Makin CA; Heyderman E
    Histopathology; 1986 Aug; 10(8):815-29. PubMed ID: 2428725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency of medullary thyroid carcinoma in an endemic goiter area.
    Schmid KW; Tötsch M; Hittmair A; Feichtinger H; Ladurner D; Hofstädter F
    Mod Pathol; 1989 Mar; 2(2):90-3. PubMed ID: 2542931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance.
    Hong SM; Kim MJ; Pi DY; Jo D; Yu E; Ro JY
    Hum Pathol; 2005 Jul; 36(7):732-40. PubMed ID: 16084941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medullary thyroid carcinoma, follicular variant.
    Cakir M; Altunbas H; Balci MK; Karayalcin U; Karpuzoglu G
    Endocr Pathol; 2002; 13(1):75-9. PubMed ID: 12114753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A metastasizing composite carcinoma of the thyroid with distinct medullary and papillary components.
    Apel RL; Alpert LC; Rizzo A; LiVolsi VA; Asa SL
    Arch Pathol Lab Med; 1994 Nov; 118(11):1143-7. PubMed ID: 7979902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma.
    Matsuki Y; Tanimoto A; Hamada T; Sasaguri Y
    Mod Pathol; 2003 Jan; 16(1):72-8. PubMed ID: 12527716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of FoxA1 expression in thyroid tumors.
    Nonaka D
    Hum Pathol; 2017 Jul; 65():217-224. PubMed ID: 28546130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.